Charles Peter Tilbery

1.5k total citations
74 papers, 941 citations indexed

About

Charles Peter Tilbery is a scholar working on Pathology and Forensic Medicine, Immunology and Neurology. According to data from OpenAlex, Charles Peter Tilbery has authored 74 papers receiving a total of 941 indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pathology and Forensic Medicine, 15 papers in Immunology and 13 papers in Neurology. Recurrent topics in Charles Peter Tilbery's work include Multiple Sclerosis Research Studies (47 papers), T-cell and Retrovirus Studies (11 papers) and Systemic Sclerosis and Related Diseases (11 papers). Charles Peter Tilbery is often cited by papers focused on Multiple Sclerosis Research Studies (47 papers), T-cell and Retrovirus Studies (11 papers) and Systemic Sclerosis and Related Diseases (11 papers). Charles Peter Tilbery collaborates with scholars based in Brazil, United States and Austria. Charles Peter Tilbery's co-authors include María Fernanda Mendes, Marcos Aurélio Moreira, Dagoberto Callegaro, Antônio José da Rocha, Milberto Scaff, Moisés Goldbaum, Alberto A. Gabbai, Flávio Túlio Braga, João Radvany and Cecília Amaro de Lólio and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the Neurological Sciences and Journal of Neuroimmunology.

In The Last Decade

Charles Peter Tilbery

68 papers receiving 898 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charles Peter Tilbery Brazil 18 626 229 149 119 108 74 941
Amir‐Hadi Maghzi United States 19 569 0.9× 291 1.3× 106 0.7× 144 1.2× 131 1.2× 44 960
Dieter Pöhlau Germany 19 728 1.2× 368 1.6× 103 0.7× 156 1.3× 174 1.6× 53 1.3k
María José Sá Portugal 19 985 1.6× 297 1.3× 134 0.9× 162 1.4× 93 0.9× 99 1.4k
Clara Grazia Chisari Italy 19 558 0.9× 324 1.4× 104 0.7× 106 0.9× 88 0.8× 72 1.0k
Donald Brunet Canada 15 412 0.7× 150 0.7× 108 0.7× 178 1.5× 267 2.5× 25 932
Nadia Reider Canada 10 921 1.5× 242 1.1× 182 1.2× 182 1.5× 62 0.6× 11 1.2k
Vahid Shaygannejad Iran 17 672 1.1× 339 1.5× 86 0.6× 123 1.0× 111 1.0× 74 945
Naila Makhani United States 16 859 1.4× 264 1.2× 105 0.7× 170 1.4× 133 1.2× 30 1.2k
Christopher McGuigan Ireland 18 598 1.0× 189 0.8× 163 1.1× 93 0.8× 98 0.9× 58 900
Egemen İdıman Türkiye 19 945 1.5× 317 1.4× 208 1.4× 190 1.6× 52 0.5× 61 1.3k

Countries citing papers authored by Charles Peter Tilbery

Since Specialization
Citations

This map shows the geographic impact of Charles Peter Tilbery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Peter Tilbery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Peter Tilbery more than expected).

Fields of papers citing papers by Charles Peter Tilbery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Peter Tilbery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Peter Tilbery. The network helps show where Charles Peter Tilbery may publish in the future.

Co-authorship network of co-authors of Charles Peter Tilbery

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Peter Tilbery. A scholar is included among the top collaborators of Charles Peter Tilbery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Peter Tilbery. Charles Peter Tilbery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Figueiredo-Godoi, Lívia Mara Alves, et al.. (2020). Oral Colonization by Candida Species in Patients with Multiple Sclerosis. Mycopathologia. 185(6). 983–991. 4 indexed citations
2.
Vitturi, Bruno Kusznir, et al.. (2019). Multiphasic disseminated encephalomyelitis associated with herpes virus infection in a patient with TLR3 deficiency. Multiple Sclerosis and Related Disorders. 36. 101379–101379. 10 indexed citations
3.
Glehn, Felipe von, Adriel S. Moraes, Vinícius Boldrini, et al.. (2016). MRZH reaction increases sensitivity for intrathecal IgG synthesis in IgG Oligoclonal band negative Multiple Sclerosis patients. Journal of Neuroimmunology. 300. 30–35. 5 indexed citations
4.
Takemoto, Maíra Libertad Soligo, Alfredo Damasceno, Yára Dadalti Fragoso, et al.. (2016). Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study. BMC Health Services Research. 16(1). 102–102. 22 indexed citations
5.
Wallner-Blazek, M, Àlex Rovira, Maria A. Rocca, et al.. (2013). Atypical idiopathic inflammatory demyelinating lesions: prognostic implications and relation to multiple sclerosis. Journal of Neurology. 260(8). 2016–2022. 56 indexed citations
6.
Lima, Gabriel Paiva da Silva, et al.. (2012). Clinical predictors of response to immunomodulators for multiple sclerosis. Arquivos de Neuro-Psiquiatria. 70(1). 12–16. 3 indexed citations
7.
Mendes, María Fernanda, et al.. (2007). Reabilitação vestibular em pacientes com esclerose múltipla remitente-recorrente. Arquivos de Neuro-Psiquiatria. 65(2A). 332–335. 10 indexed citations
8.
Mendes, María Fernanda, et al.. (2007). Adaptação transcultural e validação da escala modificada de impacto de fadiga. 1 indexed citations
9.
Moreira, Marcos Aurélio, et al.. (2006). Effect of the treatment with methylprednisolone on the cerebrospinal fluid and serum levels of CCL2 and CXCL10 chemokines in patients with active multiple sclerosis. Acta Neurologica Scandinavica. 114(2). 109–113. 29 indexed citations
10.
Mendes, María Fernanda, et al.. (2006). Avaliação da fatigabilidade em pacientes com esclerose múltipla através do dinamômetro manual. Arquivos de Neuro-Psiquiatria. 64(2a). 283–286. 5 indexed citations
11.
Tilbery, Charles Peter & Wilson Luíz Sanvito. (2005). Esclerose múltipla no Brasil: aspectos clínicos e terapêuticos. 292–292. 2 indexed citations
12.
Moreira, Marcos Aurélio, et al.. (2002). Aspectos históricos de la esclerosis múltiple. Revista de Neurología. 34(4). 378–378. 11 indexed citations
13.
Callegaro, Dagoberto, Moisés Goldbaum, Charles Peter Tilbery, et al.. (2001). The prevalence of multiple sclerosis in the city of São Paulo, Brazil, 1997. Acta Neurologica Scandinavica. 104(4). 208–213. 80 indexed citations
14.
Tilbery, Charles Peter, et al.. (1997). Uso do interferon beta natural na esclerose multipla. Resultados preliminares. 33(6). 269–272.
15.
Tilbery, Charles Peter, et al.. (1995). Esclerose múltipla simulando tumor cerebral: apresentação de caso com comprovação histopatológica. Arquivos de Neuro-Psiquiatria. 53(2). 302–306. 3 indexed citations
16.
Tilbery, Charles Peter, et al.. (1995). Esclerose múltipla: análise clínica e evolutiva de 214 casos. Arquivos de Neuro-Psiquiatria. 53(2). 203–207. 15 indexed citations
17.
Tilbery, Charles Peter. (1995). Imunologia na esclerose multipla. 31(2). 71–74.
18.
Tilbery, Charles Peter, et al.. (1994). Aumento dos receptores solúveis da interleucina-2 na esclerose múltipla: estudo preliminar em 26 pacientes. SHILAP Revista de lepidopterología. 1 indexed citations
19.
Lancellotti, Carmen Lúcia Penteado, et al.. (1989). Esclerose múltipla: estudo clínico e patológico de um caso. Arquivos de Neuro-Psiquiatria. 47(4). 455–460. 1 indexed citations
20.
Tilbery, Charles Peter, et al.. (1979). Aspectos disautonômicos da porfiria aguda intermitente: a propósito de seis casos. Arquivos de Neuro-Psiquiatria. 37(2). 151–157. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026